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Abstract and Introduction
• Cannabis in the most commonly abused illicit drug in the 
world
• In the U.S., 33 states have legalized medicinal marijuana use 
and 11 states and the District of Columbia have legalized 
recreational marijuana use
• As medical and recreational uses of this substance become 
increasingly legal, there is a need for reliable analytical 
methods that can detect and analyze cannabinoids in death 
cases where there is a question relating to the cause and 
manner of death when typical matrices are not available
• Vitreous humor is a gelatinous fluid located in the eyeball that 
is used as a matrix to test for drugs and alcohol  
• In this study, a method was developed and validated to 
quantitate THC, 11-OH-THC, THCCOOH, and CBD in vitreous 
humor and whole blood utilizing a liquid-liquid extraction and 
analysis by LC-MS/MS
Liquid-Liquid Extraction
• All analysis performed  with a Phenomenex Kinetex C18 (2.1x100 
mm, 2.6 μm particle size) with Vanquish High Pressure Liquid 
Chromatography System
• Identification/quantitation performed with a TSQ Endura QqQ
Mass Spectrometer operating in selective reaction monitoring 
mode
• Gradient elution performed with acetonitrile (Mobile Phase A) 
and 0.1% formic acid in water (Mobile Phase B)
• SRM transitions optimized by direct infusion
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1 mL of bovine 
vitreous humor or 
vitreous sample 
added to test tubes
100 μL of internal 
standard and 100 μL 
of calibrators or QC 
material added to 
samples
2 mL of water added 
to samples and 
vortexed
800 μL of 10% acetic 
acid added to 
samples and vortexed
8 mL of hexanes and 
ethyl acetate (9:1) 
added to samples
Sample tubes capped 
and rotated for 30 
minutes and 
centrifuged at 2800 
rpm for 15 minutes
Organic (upper) layer 
pulled off with a glass 
transfer pipette into a 
clean test tube and 
dried down
Samples 
reconstituted in 100 



















Materials and Methods (cont.)
Results
Results (cont.)
• Table 1. Chromatographic elution gradient.
Parameter
Positive spray voltage (V) 4000




Ion transfer tube 
temperature (⁰C)
375
Vaporizer temperature (⁰C) 425
• Table 2: Optimized MS parameters.
Method Validation
• Method validated according to SWG TOX validation guidelines
• Precision, accuracy, ion suppression, and interferences 
evaluated by various experiments 
• Method was fully validated in vitreous fluid and cross validated 
into whole blood












• Precision experiment showed that all analytes have a 
coefficient of variance within 20% of target concentration
• Accuracy experiment showed that analytes typically have an 
overall bias within 20% of target concentration
• Limit of quantitation (LOQ) for each analyte established based 
on lowest concentration at which analyte passes both 







Figure 2. Total ion chromatogram of all four analytes using developed method.
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Figure 3. Ion suppression study results.
• Ion suppression was required to be within ±25%
• All analytes fell above the upper limit of 25%
• Parallel studies performed to show that ion suppression not 
affecting quantitation
• Area count for each analyte required to be <25% of the LOQ 
for that analyte 
• Interference seen from 11-OH-THC-d3 likely due to isotope of 
this analyte
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Figure 4. Interference study results.
• Method was tested for interferences with a fentanyl drug 
panel (FEN2),  a hallucinogenic drug panel (HAL), a 
benzodiazepine panel (BZE), an antihistamine panel (AHS), and 
an antipsychotic medication panel (APS)
• All analytes within a 20% difference of target concentration in 















HAL FEN2 BZE AHS APS Upper Limit
Figure 5. Cross panel interference study results.
Comparison of Blood-Vitreous Concentrations
• Seven forensic casework samples extracted for 
comparison  
• Blood samples showed amounts of THC (ranging from .71-
8.3 ng/mL), 11-OH-THC (ranging from 0.51-1.7 ng/mL), 
and THCCOOH (ranging from 9.6-32.2 ng/mL)
Discussion and Conclusions
• A method was developed and validated to quantitate THC, 
11-OH-THC, THCCOOH, and CBD in vitreous fluid and whole 
blood by LC-MS/MS
• LOQs were typically 0.5 ng/mL with a measurement range 
reaching 250 ng/mL
• Agency issued proficiency test samples were tested using 
this method to confirm that the experienced ion 
suppression and interference were not affecting 
quantitation (parallel studies)
• Casework samples showed that blood samples testing 
positive for cannabinoids have a positive correlation for 
trace levels of THCCOOH in vitreous humor
• Low levels of cannabinoids in vitreous humor could be due 
to the compounds being mostly water insoluble or some 
other postmortem mechanism 
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Figure 6. Quantitative ion peak (left) and confirmatory ion peak (right) for THCCOOH in vitreous 
case sample.
• In 5 of the 7 cases analyzed, trace levels of THCCOOH were 
detected in the vitreous sample below the LOQ (5 ng/mL)
• Possible to confirm that THCCOOH is present due to passing 
ion ratios and consistent  retention times 
• Blood and vitreous cannabinoid concentrations considerably 
different
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